Sponsored

Leading device-based efficacy: acne clearance with Aerolase Neo Elite

September Med Esthetics Spread (1)

Aerolase: the leader in acne therapy

Clinical research validates that the Aerolase Neo Elite® is the premier device for treating all severities of acne and oil skin tones while providing the most positive patient experience in terms of comfort and fast results.

  • 92% of respondents reported that Neo Elite was as effective or more effective than other energy device treatments.1
  • 82% consider a Neo Elite as effective or more effective than topical retinoids.1
  • 94% of respondents reported that patients or parents had mentioned positive changes in self-perception since the Neo Elite.1
  • 7 Avg treatments per week at $400 per tx with 100% to your practice.1

Image1

Treatment of Mild to Severe Acne Vulgaris with a 650-Microsecond 1064-nm Nd:VAG Laser2

Authors: Nazanin Saedi, MD, Thomas Griffin Jr, MD, Sara Kelly CMA

1. (2024), Abstracts. "Response of Acne Patients to Treatment with a 650-Microsecond, 1064-nm, Pulsed Nd:YAG Laser: A Survey of 50 Dermatologists." Surg Med, 56: S6-SI85. https://doi.org/10.1002/Ism.23782

2. (2024), Abstracts. "Treatment of Mild to Severe Acne Vulgaris with a 650-Microsecond 1064-nm Nd:YAG Laser." Surg Med, 56: S5-SI85. https://doi.org/10.1002/Ism.23782

Aerolase Neo Elite: revolutionizing acne treatment

Advanced Technology for Comprehensive Care

Innovative 650-Microsecond Technology:

The Aerolase Neo Elite® utilizes advanced 650-microsecond technology, allowing deep skin penetration to reduce sebum production, suppress inflammation, and destroy C. acnes bacteria. This effectively clears active acne and prevents future breakouts.

Comprehensive Acne Management:

The Neo Elite® treats mild to severe acne and its associated side effects, including inflammatory lesions, post-inflammatory hyperpigmentation (PIH), erythema, and acne scars. It also enhances collagen production, reducing scar visibility.

Image2Versatility Across Skin Types:

Suitable for all skin types, including skin of color, the Neo Elite® delivers safe, effective treatments without the risk of burns, making it an ideal option for diverse patient populations.

Combination with Traditional Therapies:

The Neo Elite® can be used alongside traditional acne treatments like topical retinoids, oral antibiotics, and Accutane, providing faster relief and enhancing overall treatment plans.

Patient and Practice Benefits:

High patient satisfaction is reported due to the immediate and noticeable results, pain-free experience, and minimal downtime.2 Neo Elite’s ease of use, safety, and no consumable costs also make it economically advantageous for dermatology practices.

Clinical Efficacy:

Clinical data supports the Neo having the highest clearance rate compared to other acne lasers,3,4 with an 87% reduction in lesions at 90 days post-treatment,2 with significant improvements in PIH, erythema, and acne scars. High patient compliance and satisfaction were noted, with 90% satisfaction after three treatments.2

Additional Applications:

Beyond acne, the Neo Elite® effectively treats various skin conditions, offering a broad treatment palette and positive return on investment due to its versatility and cost-effectiveness.

I love it for that indication [treating PIH secondary to acne], it works well for residual active acne or residual PIH. We see reduced pigmentation and erythema after one treatment, which keeps patients coming back.

– Nazanin Saedi, MD

Image3

Qr

914.345.8300 | [email protected] | aerolase.com

@aerolase



1. LiVDerm. (n.d.). Acne awareness month: Common factors that exacerbate acne symptoms and minimize treatment efficacy. Retrieved from https://www.livderm.org/acne-awareness-month-common-factorsexacerbate-acne-symptoms-minimize-treatment-efficacy/2. (2024), Abstracts. "Treatment of Mild to Severe Acne Vulgaris with a 650-Microsecond 1064-nm Nd:YAG Laser." Surg Med, 56: S5-S185. https://doi.org/10.1002/lsm.23782.

3. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Cutera 510(K) K213461 letter, March 24, 2022, from https://www.accessdata.fda.gov/cdrh_docs/pdf21/K213461.pdf

4. Data on file, Accure Acne, Inc. https://accureacne.com/the-accure-acne-laser-system/

Disclaimer:

The above paid-for content was produced by and posted on behalf of the Sponsor. Content provided is generated solely by the Sponsor or its affiliates, and it is the Sponsor’s responsi­bility for the accuracy, completeness and validity of all information included. Perfumer & Flavorist takes steps to ensure that you will not confuse sponsored content with content produced by Perfumer & Flavorist and governed by its editorial policy.

More in Home